Biomimetic Embryo Maturation System
Microfluidic dynamic culture replacing static methods with continuous media exchange, physiological flow, and real-time monitoring.
Explore Partnership
At a Glance
Clinical Origin
Initiated by practicing IVF embryologist
Working Prototype
Hardware, software, and real-time monitoring
3 Structures
License, co-develop, or acquire
Why Dynamic Culture
Current Practice
- Outcomes
- Variable results across labs and operators
- Media Changes
- Manual intervention introduces inconsistency
- Standardization
- No reproducibility between facilities
- Data
- No real-time monitoring or audit trail
EMMA's Approach
- Media Exchange
- Continuous automated flow
- Environment
- Physiological stimulation mimicking natural conditions
- Reproducibility
- Standardized results across operators
- Monitoring
- Real-time data logging and audit trail
EMMA is in prototype stage. Performance claims reflect design objectives validated in bench testing.
What You Get
Working Prototype
- Microfluidic pump system with culture channels
- Temperature control and parameter management
- Real-time monitoring with data logging
Design Package
- Microfluidic culture system design documentation
- Software: control algorithms, monitoring interface
- Hardware: pump, channels, thermal management
Clinical Origin
- Product concept initiated by IVF embryologist
- Designed for real clinical workflow constraints
- Developed with research physics expertise
Flexible Terms
- Exclusive or non-exclusive licensing
- Co-development with shared milestones
- Full acquisition available
Where EMMA Applies
A dynamic culture platform being developed for clinical and research environments where reproducibility matters.
IVF Clinics
Designed to replace manual static culture with automated, monitored maturation. Designed to reduce operator variability across embryologists.
Reproductive Research
Controlled microfluidic environment for embryo development studies. Built-in data logging for publishable, auditable results.
Training & Standardization
Standardized culture protocols across embryologists and facilities. Reproducible environment for training new operators.
Start a Conversation
Common Questions
What is in vitro maturation (IVM)?
In vitro maturation is the process of maturing oocytes (eggs) outside the body before fertilization. Conventional IVM uses static droplet culture with manual media changes. EMMA replaces this with continuous microfluidic media exchange in a controlled environment.
What species does EMMA support?
EMMA is designed for mammalian oocyte maturation. The prototype has been developed in the context of bovine IVF and OPU-IVEP workflows. Adaptation to other species or human IVF applications is possible through the licensing or co-development process.
How does EMMA improve blastocyst rates?
EMMA provides continuous media exchange at physiological flow rates, controlled temperature and gas environment, and real-time monitoring — replacing the variability of manual static culture. Standardized conditions are designed to improve oocyte developmental competence and downstream blastocyst formation.
Is EMMA compatible with OPU-IVEP workflows?
Yes. EMMA is designed to integrate into existing ovum pick-up and in vitro embryo production pipelines. The maturation step replaces the conventional static culture dish with a microfluidic chamber while maintaining compatibility with standard IVF downstream steps.
Connected to IVF research or reproductive technology? We welcome introductions.